Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop-Reference-Cited by-同舟云学术

Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop

Published:2020-07-03 Issue:9 Volume:10 Page:1037-1042
ISSN:2042-6976
Container-title:International Forum of Allergy & Rhinology
language:en
Short-container-title:Int Forum Allergy Rhinol.

Author:

Roland Lauren T.¹^ORCID,Smith Timothy L.²^ORCID,Schlosser Rodney J.³,Soler Zachary M.³,Peters Anju T.⁴,Laidlaw Tanya M.⁵,Bleier Benjamin S.⁶^ORCID,Ramakrishnan Vijay⁷^ORCID,Toskala Elina⁸,Kennedy David W.⁹,Luong Amber U.¹⁰

Affiliation:

1. Department of OtolaryngologyUniversity of California San Francisco CA

2. Department of OtolaryngologyOregon Health and Science University Portland OR

3. Department of OtolaryngologyMedical University of South Carolina Charleston SC

4. Division of Allergy‐ImmunologyFeinberg School of MedicineNorthwestern University Chicago IL

5. Department of MedicineBrigham and Women's HospitalHarvard Medical School Boston MA

6. Department of OtolaryngologyHarvard Medical School Boston MA

7. Department of OtolaryngologyUniversity of Colorado Aurora CO

8. Department of OtolaryngologyThomas Jefferson University Philadelphia PA

9. Department of Otolaryngology, Perelman School of MedicineUniversity of Pennsylvania Philadelphia PA

10. Department of Otolaryngology, Head and Neck SurgeryMcGovern Medical School, University of Texas Health Science Center at Houston Houston TX

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alr.22633

Reference42 articles.

1. Chronic Rhinosinusitis with Nasal Polyps

2. Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting

3. The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP)

4. Role of Medical Therapy in the Management of Nasal Polyps

5. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review;Current Allergy and Asthma Reports;2023-11-22

2. Pathogenesis of chronic rhinosinusitis with nasal polyp and a prominent T2 endotype;Heliyon;2023-09

3. Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study;Current Allergy and Asthma Reports;2023-08-30

4. Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients;The Laryngoscope;2023-08-26

5. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP);International Forum of Allergy & Rhinology;2023-08-10